Efficacy of l‐Arginine treatment in patients with HTLV‐1‐associated neurological disease
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51715
Abstract: HTLV‐1 infection causes HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP), resulting in loss of motor function. In this Phase 2 trial, we assessed the efficacy and safety of l‐arginine in patients with HAM/TSP. read more here.
Keywords: treatment patients; htlv associated; efficacy arginine; efficacy ... See more keywords